BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20651350)

  • 1. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.
    Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
    Anticancer Res; 2010 Jun; 30(6):2049-54. PubMed ID: 20651350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
    Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
    Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1).
    Upadhyay S; Neburi M; Chinni SR; Alhasan S; Miller F; Sarkar FH
    Clin Cancer Res; 2001 Jun; 7(6):1782-9. PubMed ID: 11410520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of growth inhibition by genistein of human breast carcinoma].
    Shao Z; Shen Z
    Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):325-8. PubMed ID: 11776565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y; Mi C
    Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis.
    Shao ZM; Alpaugh ML; Fontana JA; Barsky SH
    J Cell Biochem; 1998 Apr; 69(1):44-54. PubMed ID: 9513045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
    Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein.
    Li Y; Upadhyay S; Bhuiyan M; Sarkar FH
    Oncogene; 1999 May; 18(20):3166-72. PubMed ID: 10340389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
    Elstrodt F; Hollestelle A; Nagel JH; Gorin M; Wasielewski M; van den Ouweland A; Merajver SD; Ethier SP; Schutte M
    Cancer Res; 2006 Jan; 66(1):41-5. PubMed ID: 16397213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.
    Majid S; Kikuno N; Nelles J; Noonan E; Tanaka Y; Kawamoto K; Hirata H; Li LC; Zhao H; Okino ST; Place RF; Pookot D; Dahiya R
    Cancer Res; 2008 Apr; 68(8):2736-44. PubMed ID: 18413741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling of breast cancer cells exposed to soy phytoestrogens after BRCA1 knockdown with a whole human genome microarray approach.
    Satih S; Chalabi N; Rabiau N; Bignon YJ; Bernard-Gallon DJ
    Nutr Cancer; 2010; 62(5):659-67. PubMed ID: 20574927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms.
    Tophkhane C; Yang S; Bales W; Archer L; Osunkoya A; Thor AD; Yang X
    Int J Oncol; 2007 Oct; 31(4):867-74. PubMed ID: 17786319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway.
    Wang YQ; Zhang JR; Li SD; He YY; Yang YX; Liu XL; Wan XP
    Cancer Sci; 2010 Jul; 101(7):1618-23. PubMed ID: 20487263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.
    Guillot C; Falette N; Paperin MP; Courtois S; Gentil-Perret A; Treilleux I; Ozturk M; Puisieux A
    Oncogene; 1997 Jan; 14(1):45-52. PubMed ID: 9010231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
    Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
    Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on Breast Cancer Susceptibility gene-1 (BRCA1) status.
    Thasni KA; Rojini G; Rakesh SN; Ratheeshkumar T; Babu MS; Srinivas G; Banerji A; Srinivas P
    Eur J Pharmacol; 2008 Jul; 588(2-3):158-64. PubMed ID: 18514188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.